{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:56:13Z","timestamp":1790880973159,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"INSERM - Minist\u00e8re de la Recherche","award":["01P0751 - 01P0752 - 01P0753 - 01P0754 - 01P0755"],"award-info":[{"award-number":["01P0751 - 01P0752 - 01P0753 - 01P0754 - 01P0755"]}]},{"DOI":"10.13039\/501100006289","name":"\u00c9lectricit\u00e9 de France","doi-asserted-by":"publisher","award":["EP 2002-03, EP 2004-03"],"award-info":[{"award-number":["EP 2002-03, EP 2004-03"]}],"id":[{"id":"10.13039\/501100006289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006289","name":"\u00c9lectricit\u00e9 de France","doi-asserted-by":"publisher","award":["RB 2016-22"],"award-info":[{"award-number":["RB 2016-22"]}],"id":[{"id":"10.13039\/501100006289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["2001009761 and 2005011201"],"award-info":[{"award-number":["2001009761 and 2005011201"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"crossref","award":["PRE04\/NA, PRE07\/NA and PRE2015 LNCC\/NA"],"award-info":[{"award-number":["PRE04\/NA, PRE07\/NA and PRE2015 LNCC\/NA"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ligue Comit\u00e9 du Maine et Loire","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100008018","name":"Mutuelle G\u00e9n\u00e9rale de l'Education Nationale","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100008018","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ITMO Sant\u00e9 Publique - AVIESAN","award":["AAP12-COH-110"],"award-info":[{"award-number":["AAP12-COH-110"]}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa-9578"],"award-info":[{"award-number":["INCa-9578"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa-DGOS-4654"],"award-info":[{"award-number":["INCa-DGOS-4654"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["PJA 20151203365"],"award-info":[{"award-number":["PJA 20151203365"]}],"id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-EQPX-03"],"award-info":[{"award-number":["ANR-10-EQPX-03"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-0951-9","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T11:12:59Z","timestamp":1523963579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers"],"prefix":"10.1186","volume":"20","author":[{"name":"CoF-AT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Renault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GENESIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"kConFab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"Mebirouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bataillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Cavaciuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Beauvallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Eon-Marchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Gabrielle","family":"Dondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Dubois","family":"d\u2019Enghien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Laug\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Chemlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bi\u00e8che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Baulande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Berthet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Buecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fresnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gauthier-Villars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Janin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Maugard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Moutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Venat-Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Zattara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Gladieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Coupier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-4549","authenticated-orcid":false,"given":"Fabienne","family":"Lesueur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"issue":"2","key":"951_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","volume":"128","author":"R Micol","year":"2011","unstructured":"Micol R, Ben Slama L, Suarez F, Le Mignot L, Beaute J, Mahlaoui N, Dubois d\u2019Enghien C, Lauge A, Hall J, Couturier J, et al. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol. 2011;128(2):382\u20139.e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"951_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d\u2019Enghien C, Brousse N, Jais JP, Fischer A, Hermine O, Stoppa-Lyonnet D. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol. 2015;33(2):202\u20138.","journal-title":"J Clin Oncol."},{"issue":"2","key":"951_CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","volume":"87","author":"AM Taylor","year":"1996","unstructured":"Taylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87(2):423\u201338.","journal-title":"Blood."},{"issue":"4","key":"951_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/gcc.2870020412","volume":"2","author":"AL Borresen","year":"1990","unstructured":"Borresen AL, Andersen TI, Tretli S, Heiberg A, Moller P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer. 1990;2(4):339\u201340.","journal-title":"Genes Chromosomes Cancer."},{"issue":"1","key":"951_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-4608(90)90004-T","volume":"46","author":"M Swift","year":"1990","unstructured":"Swift M, Chase CL, Morrell D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet. 1990;46(1):21\u20137.","journal-title":"Cancer Genet Cytogenet."},{"issue":"11","key":"951_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","volume":"97","author":"D Thompson","year":"2005","unstructured":"Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A, Byrd P, Taylor M, Easton DF. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst. 2005;97(11):813\u201322.","journal-title":"J Natl Cancer Inst."},{"key":"951_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1017\/S0022029905001147","volume":"72 Spec No","author":"N Andrieu","year":"2005","unstructured":"Andrieu N, Cavaciuti E, Laug\u00e9 A, Ossian K, Janin N, Hall J, Stoppa-Lyonnet D. Ataxia-telangiectasia genes and breast cancer risk in a French family study. J Dairy Res. 2005;72 Spec No:73\u201380.","journal-title":"J Dairy Res"},{"issue":"10","key":"951_CR8","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/carcin\/bgx074","volume":"38","author":"AL Renault","year":"2017","unstructured":"Renault AL, Mebirouk N, Cavaciuti E, Le Gal D, Lecarpentier J, d\u2019Enghien CD, Laug\u00e9 A, Dondon MG, Labb\u00e9 M, Lesca G, et al. Telomere length, ATM mutation status and cancer risk in ataxia-telangiectasia families. Carcinogenesis. 2017;38(10):994\u20131003.","journal-title":"Carcinogenesis."},{"issue":"8","key":"951_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","volume":"38","author":"A Renwick","year":"2006","unstructured":"Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006;38(8):873\u20135.","journal-title":"Nat Genet."},{"issue":"4","key":"951_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ajhg.2009.08.018","volume":"85","author":"SV Tavtigian","year":"2009","unstructured":"Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, Lesueur F, Byrnes GB, Chuang SC, Forey N, et al. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet. 2009;85(4):427\u201346.","journal-title":"Am J Hum Genet."},{"issue":"23","key":"951_CR11","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372(23):2243\u201357.","journal-title":"N Engl J Med."},{"issue":"1","key":"951_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","volume":"15","author":"MB Daly","year":"2017","unstructured":"Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, et al. NCCN Guidelines Insights: Genetic\/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. J Natl Compr Cancer Netw. 2017;15(1):9\u201320.","journal-title":"J Natl Compr Cancer Netw."},{"issue":"4","key":"951_CR13","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","volume":"13","author":"DE Goldgar","year":"2011","unstructured":"Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, Terry MB, Daly MJ, Buys SM, Southey MC, et al. Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res. 2011;13(4):R73.","journal-title":"Breast Cancer Res."},{"issue":"2","key":"951_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cge.12710","volume":"90","author":"NJ van Os","year":"2016","unstructured":"van Os NJ, Roeleveld N, Weemaes CM, Jongmans MC, Janssens GO, Taylor AM, Hoogerbrugge N, Willemsen MA. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline. Clin Genet. 2016;90(2):105\u201317.","journal-title":"Clin Genet."},{"issue":"5","key":"951_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1365-2559.2006.02538.x","volume":"49","author":"RL Balleine","year":"2006","unstructured":"Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H. kConFab Investigators, Kirk JA. Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology. 2006;49(5):523\u201332.","journal-title":"Histopathology."},{"issue":"4","key":"951_CR16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/path.2728","volume":"221","author":"N Waddell","year":"2010","unstructured":"Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J, da Silva L, Vargas AC, Reid L. kConFab Investigators, et al. Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay. J Pathol. 2010;221(4):452\u201361.","journal-title":"J Pathol."},{"issue":"11","key":"951_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/gcc.22482","volume":"56","author":"V Bubien","year":"2017","unstructured":"Bubien V, Bonnet F, Dupiot-Chiron J, Barouk-Simonet E, Jones N, de Reynies A, MacGrogan G, Sevenet N, Letouz\u00e9 E, Longy M. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: a proof of principle study. Genes Chromosomes Cancer. 2017;56(11):788\u201399.","journal-title":"Genes Chromosomes Cancer."},{"issue":"21","key":"951_CR18","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1158\/0008-5472.CAN-12-1470","volume":"72","author":"T Popova","year":"2012","unstructured":"Popova T, Manie E, Rieunier G, Caux-Moncoutier V, Tirapo C, Dubois T, Delattre O, Sigal-Zafrani B, Bollet M, Longy M, et al. Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1\/2 inactivation. Cancer Res. 2012;72(21):5454\u201362.","journal-title":"Cancer Res."},{"issue":"7","key":"951_CR19","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/sj.bjc.6690460","volume":"80","author":"N Janin","year":"1999","unstructured":"Janin N, Andrieu N, Ossian K, Lauge A, Croquette MF, Griscelli C, Debre M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer. 1999;80(7):1042\u20135.","journal-title":"Br J Cancer."},{"key":"951_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12885-015-2028-9","volume":"16","author":"OM Sinilnikova","year":"2016","unstructured":"Sinilnikova OM, Dondon MG, Eon-Marchais S, Damiola F, Barjhoux L, Marcou M, Verny-Pierre C, Sornin V, Toulemonde L, Beauvallet J, et al. GENESIS: a French national resource to study the missing heritability of breast cancer. BMC Cancer. 2016;16:13.","journal-title":"BMC Cancer."},{"issue":"1","key":"951_CR21","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/bcr1377","volume":"8","author":"GJ Mann","year":"2006","unstructured":"Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006;8(1):R12.","journal-title":"Breast Cancer Res."},{"issue":"11","key":"951_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/humu.20892","volume":"29","author":"SV Tavtigian","year":"2008","unstructured":"Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB, Group IUGVW. In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat. 2008;29(11):1327\u201336.","journal-title":"Hum Mutat."},{"issue":"3","key":"951_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1040-8428(99)00034-7","volume":"31","author":"CW Elston","year":"1999","unstructured":"Elston CW, Ellis IO, Pinder SE. Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol. 1999;31(3):209\u201323.","journal-title":"Crit Rev Oncol Hematol."},{"key":"951_CR24","first-page":"116","volume":"86","author":"W B\u00f6cker","year":"2002","unstructured":"B\u00f6cker W. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics [in German]. Verh Dtsch Ges Pathol. 2002;86:116\u20139.","journal-title":"Verh Dtsch Ges Pathol."},{"issue":"9","key":"951_CR25","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Th\u00fcrlimann B, Senn HJ. Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24(9):2206\u201323.","journal-title":"Ann Oncol."},{"issue":"11","key":"951_CR26","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/gb-2009-10-11-r128","volume":"10","author":"T Popova","year":"2009","unstructured":"Popova T, Manie E, Stoppa-Lyonnet D, Rigaill G, Barillot E, Stern MH. Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays. Genome Biol. 2009;10(11):R128.","journal-title":"Genome Biol."},{"issue":"17","key":"951_CR27","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/bioinformatics\/btl359","volume":"22","author":"P La Rosa","year":"2006","unstructured":"La Rosa P, Viara E, Hupe P, Pierron G, Liva S, Neuvial P, Brito I, Lair S, Servant N, Robine N, et al. VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics. 2006;22(17):2066\u201373.","journal-title":"Bioinformatics."},{"issue":"14","key":"951_CR28","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics."},{"issue":"16","key":"951_CR29","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen R, Seshan VE. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 2016;44(16):e131.","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"951_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568\u201376.","journal-title":"Genome Res."},{"issue":"7418","key":"951_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature."},{"issue":"12","key":"951_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/1055-9965.EPI-16-0427","volume":"25","author":"M Valla","year":"2016","unstructured":"Valla M, Vatten LJ, Engstrom MJ, Haugen OA, Akslen LA, Bjorngaard JH, Hagen AI, Ytterhus B, Bofin AM, Opdahl S. Molecular subtypes of breast cancer: long-term incidence trends and prognostic differences. Cancer Epidemiol Biomark Prev. 2016;25(12):1625\u201334.","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"21","key":"951_CR33","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","volume":"16","author":"TO Nielsen","year":"2010","unstructured":"Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, Davies SR, Snider J, Stijleman IJ, Reed J, et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res. 2010;16(21):5222\u201332.","journal-title":"Clin Cancer Res."},{"issue":"23","key":"951_CR34","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","volume":"24","author":"S Paik","year":"2006","unstructured":"Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24(23):3726\u201334.","journal-title":"J Clin Oncol."},{"issue":"4","key":"951_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ijc.29829","volume":"138","author":"E Manie","year":"2016","unstructured":"Manie E, Popova T, Battistella A, Tarabeux J, Caux-Moncoutier V, Golmard L, Smith NK, Mueller CR, Mariani O, Sigal-Zafrani B, et al. Genomic hallmarks of homologous recombination deficiency in invasive breast carcinomas. Int J Cancer. 2016;138(4):891\u2013900.","journal-title":"Int J Cancer."},{"issue":"7403","key":"951_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352.","journal-title":"Nature."},{"issue":"12","key":"951_CR37","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1002\/ijc.28315","volume":"133","author":"N Pecuchet","year":"2013","unstructured":"Pecuchet N, Popova T, Manie E, Lucchesi C, Battistella A, Vincent-Salomon A, Caux-Moncoutier V, Bollet M, Sigal-Zafrani B, Sastre-Garau X, et al. Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas. Int J Cancer. 2013;133(12):2834\u201342.","journal-title":"Int J Cancer."},{"issue":"5","key":"951_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov."},{"issue":"11","key":"951_CR39","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jmedgenet-2017-104588","volume":"54","author":"B Decker","year":"2017","unstructured":"Decker B, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Ahmed S, Baynes C, Conroy DM, et al. Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks. J Med Genet. 2017;54(11):732\u201341.","journal-title":"J Med Genet."},{"issue":"6","key":"951_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S1470-2045(15)70142-7","volume":"16","author":"C Cybulski","year":"2015","unstructured":"Cybulski C, Kluzniak W, Huzarski T, Wokolorczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, Debniak T, Gorski B, et al. Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol. 2015;16(6):638\u201344.","journal-title":"Lancet Oncol."},{"issue":"3","key":"951_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.breast.2006.12.003","volume":"16","author":"A Musolino","year":"2007","unstructured":"Musolino A, Bella MA, Bortesi B, Michiara M, Naldi N, Zanelli P, Capelletti M, Pezzuolo D, Camisa R, Savi M, et al. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. Breast. 2007;16(3):280\u201392.","journal-title":"Breast."},{"issue":"1","key":"951_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1399-0004.2008.01111.x","volume":"75","author":"C Cybulski","year":"2009","unstructured":"Cybulski C, Huzarski T, Byrski T, Gronwald J, Debniak T, Jakubowska A, G\u00f3rski B, Woko\u0142orczyk D, Masoj\u0107 B, Narod SA, et al. Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention. Clin Genet. 2009;75(1):72\u20138.","journal-title":"Clin Genet."},{"issue":"4","key":"951_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pathol.2017.03.002","volume":"49","author":"MG Keeney","year":"2017","unstructured":"Keeney MG, Couch FJ, Visscher DW, Lindor NM. Non-BRCA familial breast cancer: review of reported pathology and molecular findings. Pathology. 2017;49(4):363\u201370.","journal-title":"Pathology."},{"key":"951_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1186\/s12885-015-1880-y","volume":"15","author":"MP Massink","year":"2015","unstructured":"Massink MP, Kooi IE, Martens JW, Waisfisz Q, Meijers-Heijboer H. Genomic profiling of CHEK2*1100delC-mutated breast carcinomas. BMC Cancer. 2015;15:877.","journal-title":"BMC Cancer."},{"issue":"1","key":"951_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomark Prev. 2012;21(1):134\u201347.","journal-title":"Cancer Epidemiol Biomark Prev."},{"issue":"21","key":"951_CR46","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","volume":"297","author":"P Kaurah","year":"2007","unstructured":"Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007;297(21):2360\u201372.","journal-title":"JAMA."},{"issue":"4","key":"951_CR47","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/bcr2626","volume":"12","author":"G Banneau","year":"2010","unstructured":"Banneau G, Guedj M, MacGrogan G, de Mascarel I, Velasco V, Schiappa R, Bonadona V, David A, Dugast C, Gilbert-Dussardier B, et al. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res. 2010;12(4):R63.","journal-title":"Breast Cancer Res."},{"issue":"10","key":"951_CR48","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/bjc.2012.451","volume":"107","author":"V Abkevich","year":"2012","unstructured":"Abkevich V, Timms KM, Hennessy BT, Potter J, Carey MS, Meyer LA, Smith-McCune K, Broaddus R, Lu KH, Chen J, et al. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br J Cancer. 2012;107(10):1776\u201382.","journal-title":"Br J Cancer."},{"issue":"10","key":"951_CR49","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ng.3934","volume":"49","author":"P Polak","year":"2017","unstructured":"Polak P, Kim J, Braunstein LZ, Karlic R, Haradhavala NJ, Tiao G, Rosebrock D, Livitz D, Kubler K, Mouw KW, et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat Genet. 2017;49(10):1476\u201386.","journal-title":"Nat Genet."},{"issue":"18","key":"951_CR50","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","volume":"373","author":"J Mateo","year":"2015","unstructured":"Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, Nava Rodrigues D, Robinson D, Omlin A, Tunariu N, et al. DNA-repair defects and olaparib in metastatic prostate cancer. N Engl J Med. 2015;373(18):1697\u2013708.","journal-title":"N Engl J Med."},{"issue":"8","key":"951_CR51","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","volume":"15","author":"M Choi","year":"2016","unstructured":"Choi M, Kipps T, Kurzrock R. ATM mutations in cancer: therapeutic implications. Mol Cancer Ther. 2016;15(8):1781\u201391.","journal-title":"Mol Cancer Ther."},{"issue":"12","key":"951_CR52","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.febslet.2010.03.044","volume":"584","author":"AP Sagona","year":"2010","unstructured":"Sagona AP, Stenmark H. Cytokinesis and cancer. FEBS Lett. 2010;584(12):2652\u201361.","journal-title":"FEBS Lett."},{"issue":"3","key":"951_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejca.2011.11.008","volume":"48","author":"AB Jonsdottir","year":"2012","unstructured":"Jonsdottir AB, Stefansson OA, Bjornsson J, Jonasson JG, Ogmundsdottir HM, Eyfjord JE. Tetraploidy in BRCA2 breast tumours. Eur J Cancer. 2012;48(3):305\u201310.","journal-title":"Eur J Cancer."},{"issue":"8","key":"951_CR54","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/sj.onc.1202453","volume":"18","author":"MG di Iasio","year":"1999","unstructured":"di Iasio MG, Calin G, Tibiletti MG, Vorechovsky I, Benediktsson KP, Taramelli R, Barbanti-Brodano G, Negrini M. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene. 1999;18(8):1635\u20138.","journal-title":"Oncogene."},{"issue":"4","key":"951_CR55","first-page":"849","volume":"13","author":"PG Rio","year":"1998","unstructured":"Rio PG, Pernin D, Bay JO, Albuisson E, Kwiatkowski F, De Latour M, Bernard-Gallon DJ, Bignon YJ. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int J Oncol. 1998;13(4):849\u201353.","journal-title":"Int J Oncol."},{"issue":"9","key":"951_CR56","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc2401","volume":"8","author":"ES Knudsen","year":"2008","unstructured":"Knudsen ES, Knudsen KE. Tailoring to RB: tumour suppressor status and therapeutic response. Nat Rev Cancer. 2008;8(9):714\u201324.","journal-title":"Nat Rev Cancer."},{"key":"951_CR57","doi-asserted-by":"publisher","first-page":"43379","DOI":"10.1038\/srep43379","volume":"7","author":"N Koide","year":"2017","unstructured":"Koide N, Kasamatsu A, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, et al. Evidence for critical role of lymphocyte cytosolic protein 1 in oral cancer. Sci Rep. 2017;7:43379.","journal-title":"Sci Rep."},{"issue":"1","key":"951_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAI.0000000000000041","volume":"23","author":"JS Cho","year":"2015","unstructured":"Cho JS, Park MH, Lee JS, Yoon JH. Reduced MUC4 expression is a late event in breast carcinogenesis and is correlated with increased infiltration of immune cells as well as promoter hypermethylation in invasive breast carcinoma. Appl Immunohistochem Mol Morphol. 2015;23(1):44\u201353.","journal-title":"Appl Immunohistochem Mol Morphol."},{"issue":"3","key":"951_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/path.4837","volume":"241","author":"C Marchio","year":"2017","unstructured":"Marchio C, Geyer FC, Ng CK, Piscuoglio S, De Filippo MR, Cupo M, Schultheis AM, Lim RS, Burke KA, Guerini-Rocco E, et al. The genetic landscape of breast carcinomas with neuroendocrine differentiation. J Pathol. 2017;241(3):405\u201319.","journal-title":"J Pathol."},{"issue":"7463","key":"951_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415\u201321.","journal-title":"Nature."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-0951-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T02:46:19Z","timestamp":1720233979000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-0951-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-0951-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent for genetic studies and use of medical records for the present analyses was obtained from all participants enrolled in the Retro-AT, CoF-AT, GENESIS and kConFab research programs. The appropriate local ethics committee (Comit\u00e9 de Protection des Personnes [CCP] Ile-de-France III 2002\/2006) and the French data protection authority (Commission Nationale de l\u2019Informatique et des Libert\u00e9s [CNIL]) approved the individual resource collections; Retro-AT, CoF-AT, and GENESIS study protocols; and the specific study on tumour material ofATMcarriers. The kConFab resource collection and the specific study on tumour material ofATMcarriers were approved by the Peter MacCallum Cancer Centre Ethics Committee and the Queensland Institute of Medical Research Human Research Ethics Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"28"}}